Abstract
Although human cancer is often surrounded by immune cells, only a small number are tumor-reactive T cells that recognize the tumor antigens and are able to eliminate the cancer cells. Ye and colleagues now found that many of these tumor-reactive T cells are marked by expressing CD137, a T-cell costimulatory receptor. Clin Cancer Res; 20(1); 3-5. © 2013 AACR.
Cite
CITATION STYLE
APA
Zhu, Y., & Chen, L. (2014). CD137 as a biomarker for tumor-reactive T cells: Finding gold in the desert. Clinical Cancer Research, 20(1), 3–5. https://doi.org/10.1158/1078-0432.CCR-13-2573
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free